Get Started

IHRMF

PINK ISHARES MSCI JPN ORD
Nov 11, 2026 · 5:16 AM ET EOD Market Closed

$23.84 ↓ -0.56 (-2.28%) Trading Down from the previous close of $24.40, and at the day’s high of $23.84

YTD change
-2.73%
vs 20-day SMA
-5.24%
vs 200-day SMA
N/A

Price ranges

Previous day
$23.84 $23.84
open $23.84 close $23.84
+$0.00 (+0.00%)
Today
$23.84 $23.84
$23.84
Past week
$24.40 $25.09
from $25.05 now $23.84
-$1.21 (-4.82%)
Past month
$24.40 $25.78
from $25.51 now $23.84
-$1.66 (-6.52%)
This year
$21.19 $25.78
from $24.51 now $23.84
-$0.67 (-2.73%)

Price & Performance

-0.61 (-2.50%) / 6M

$23.28$24.17$25.06$25.96May 13Jul 20Nov 10

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 7.5% away from all-time highs of $25.78
  • IHRMF is down 3% since the beginning of the year
  • IHRMF is down 3% over the past 12 months
  • IHRMF is down 7% over the past 1 month

IHRMF reads n/a: the 12-month move is +12.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Finance and Insurance
Sub Sector Securities, Commodity Contracts, and Other Financial Investments and Related Activities
Market cap N/A

Competitor comparison

TickerCompany PriceChange
STT State Street Corporation $171.62 +0.43%
ETHE Grayscale Ethereum Staking ETF Shares $16.47 -3.29%
DHT.UN.CAT DRI HEALTHCARE TRUST UNIT $19.49 -0.05%
PPLT abrdn Physical Platinum Shares ETF $13.94 -2.11%
FXE Invesco CurrencyShares Euro Currency Trust $103.02 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.